Kaplan RM, Groessl EJ.Applications of cost-effectiveness methodologies in behavioral medicine. J Consult Clin Psychol.2002;70: 482-493.
2.
Lamm RD.The Brave New World of Health Care. Denver, Colo: Fulcrum; 2003.
3.
Toobert DJ, Glasgow RE, Strycker LA, et al.Biologic and quality of life outcomes from the Mediterranean Lifestyle Program: a randomized clinical trial. Diabetes Care. 2003;26: 2288-2293.
4.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med.1993;329: 977-986.
5.
Knowler WC, Barrett-Connor E, Fowler SE, et al.Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med.2002;346: 393-403.
6.
The Diabetes Control and Complications Trial Research Group. Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabetes Care. 1995;18: 1468-1478.
7.
Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care. 2003;26: 36-47.
8.
Toobert DJ, Strycker LA, Glasgow RE, Barrera M, Bagdade JD.Enhancing support for health behavior change among women at risk for heart disease: the Mediterranean Lifestyle Trial. Health Educ Res.2002;17: 574-585.
9.
American Diabetes Association.. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2002;25: 213-229.
10.
Grundy SM, D’Agostino RB Sr, Mosca L, et al.Cardiovascular risk assessment based on US cohort studies. Circulation.2001;104: 491-496.
11.
Lee WL, Cheung AM, Cape D, Zinman B.Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care. 2000;23: 962-968.
12.
Toobert DJ, Strycker LA, Glasgow RE, Bagdade JD.If you build it, will they come? Reach and adoption associated with a comprehensive lifestyle management program for women with type 2 diabetes. Patient Educ Couns.2002;1646: 1-7.
13.
Toobert DJ, Strycker LA, Glasgow RE, Barrera M, Bagdade JD.Enhancing support for health behavior change among women at risk for heart disease: the Mediterranean Lifestyle Trial. Health Educ Res.2002;17: 574-585.
14.
Toobert DJ, Strycker LA, Glasgow RE, Barrera M, Angell K.Effects of the Mediterranean Lifestyle Program on multiple risk behaviors and psychosocial outcomes among women at risk for heart disease. Ann Behav Med.2005;29: 128-137.
15.
Gold M, Siegel J, Russell L, Weinstein M.Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
16.
Meenan R, Stevens V, Hornbrook M, et al.Cost-effectiveness of a hospital-based smoking cessation intervention. Med Care. 1998;36: 670-678.
17.
Drummond MF, O’Brien BJ, Stoddart GL, Torrance GW.Methods for the Economic Evaluation of Health Care Programmes. 2nd ed.Oxford, UK: Oxford University Press; 1997.
18.
Consumer Price Index for All Urban Consumers and Medical Consumer Price Index. Available at: http://www.economagic.com/blscu.htm. Accessed May 20, 2005.
19.
Stewart AL, Verboncoeur CJ, McLellan BY, et al.Physical activity outcomes of CHAMPS II: a physical activity promotion program for older adults. J Gerontol A Biol Sci Med Sci.2001;56: M465-M470.
20.
Patterson RE, Kristal A, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T.Measurement characteristics of the Women’s Health Initiative Food Frequency Questionnaire. Ann Epidemiol.1999;9: 178-187.
21.
Polonsky WH, Anderson BJ, Lohrer PA, et al.Assessment of diabetes-related distress. Diabetes Care. 1995;18: 754-760.
22.
Ornish D, Brown SE, Scherwitz LW, et al.Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet.1990;336: 129-133.
23.
Herman WH, Hoerger TJ, Brandle M, et al.Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med.2005;142: 323-332.
24.
The Diabetes Control and Complications Trial Research Group. Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabetes Care. 1995;18: 1468-1478.
25.
Glasgow RE, La Chance P, Toobert DJ, et al.Long-term effects and costs of brief behavioral dietary intervention for patients with diabetes delivered from the medical office. Patient Educ Couns.1997;32: 175-184.
